GBI Research, Sep 2011, Pages: 142
geographies.
- Exploit in-licensing and out-licensing opportunities by identifying products to fill their portfolio gaps.
- Develop key strategic initiatives by studying the key strategies of the top
Frost & Sullivan, Oct 1997
Forecasts of the European Antiviral Drugs Market
- Strategic Analysis and Forecasts of the European Antiviral Vaccines Market
- Strategic Analysis and Forecasts of the European Interferons Market
Biophoenix Limited, July 2009, Pages: 275
Biosimilars and Biobetters: Positioning for a New Market As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to
Decision Resources, Inc., Feb 2010, Pages: 32
to treating HIV infections?
- Although most development activity is directed at HCV and HIV, other commercial opportunities are available in antivirals.
Which diseases offer the potential for the
Global Industry Analysts, Inc., Feb 2011, Pages: 349
Biosimilars - Global Strategic Business Report This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for US, Europe, and
Markets and Markets, Sep 2009, Pages: 189
involved with the high investment and the possible failure of the drug during development stages. However, opportunities for biosimilarss market is immense, as biologics worth US$25 billion are going to be
Datamonitor, Feb 2011, Pages: 123
decisions in hepatitis B, and the opportunitiesand threats shaping the Chinese market. Executive Summary
Strategic scoping and focus
Datamonitor insight into the Chinese hepatitis B market
Related
Datamonitor, Dec 2009, Pages: 160
-stage clinical development.
Scope
- Strategic analysis of therapeutic vaccine pipelines and key clinical candidates across several disease areas outside cancer
- Thorough assessment of opportunities
Venture Planning Group, Oct 2010, Pages: 590
portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunitiesandstrategic recommendations for suppliers.
Venture Planning Group, Oct 2010, Pages: 575
, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunitiesandstrategic recommendations for suppliers.
Venture Planning Group, Oct 2010, Pages: 585
, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunitiesandstrategic recommendations for suppliers.
Venture Planning Group, Oct 2010, Pages: 585
portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunitiesandstrategic recommendations for suppliers.
Informa Healthcare, Jan 2007, Pages: 237
arm readers with the strategic information they need to face the new opportunities presented by this market trend, as well as its challenges.
With regulation playing a key role in the evolving
Venture Planning Group, June 2011, Pages: 1200
sales projections by country.
Business OpportunitiesandStrategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next ten years
GBI Research, Dec 2009, Pages: 97
markets poised for strong growth
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill their portfolio gaps
- Develop key strategic initiatives by studying the
Venture Planning Group, Oct 2010, Pages: 565
, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Venture Planning Group, Oct 2010, Pages: 620
shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunitiesandstrategic recommendations
